Glycaemic Control and Diabetic Retinopathy

References

• Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168–188; 252–263
   Google Scholar
• Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia 1978; 15: 143–152
   PubMed Web of Science ®Google Scholar
• Gonen B, Rochman H, Rubenstein A H. Metabolic control in diabetic patients: Assessment by hemoglobin A, values. Metabolism 1979; 28: 448–455
   PubMed Web of Science ®Google Scholar
• Job D, Eschwege E, Guyot-Argenton C. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 1976; 25: 463–469
   PubMed Web of Science ®Google Scholar
• Ashikaga T, Borodic G, Sims E AH. Multiple daily insulin injections in the treatment of diabetic retinopathy: The Job study revisited. Diabetes 1978; 27: 592–596
   Google Scholar
• Pickup J C, Keen H, Parsons J A. Continuous subcutaneous insulin infusion: An approach to achieving normoglycaemia. Br Med J 1978; 1: 204–207
   PubMed Web of Science ®Google Scholar
• Tamborlane W V, Sherwin R S, Genel M. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573–578
   PubMed Web of Science ®Google Scholar
• Champion M C, Shepherd G AA, Rodger N W. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 1980; 29: 206–215
   PubMed Web of Science ®Google Scholar
• Sonksen P H, Judd S L, Lowy C. Home monitoring of blood glucose. Lancet 1978; 1: 729–732
   PubMed Web of Science ®Google Scholar
• Walford S, Gale E AM, Allison S P. Self-monitoring of blood glucose. Lancet 1978; 1: 732–735
   PubMed Web of Science ®Google Scholar
• Jeppson I-O, Franzen B, Nilsson K O. Determinations of the glycosylated haemoglobin fractions HbA1c in diabetes mellitus by thin layer electrofocussing. Sci Tools 1978; 25: 69–72
   Google Scholar
• Pickup J C, White M C, Keen H. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 1979; 2: 870–873
   PubMed Web of Science ®Google Scholar
• Tamborlane W V, Sherwin R S, Genel M. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 1980; 68: 190–196
   PubMed Web of Science ®Google Scholar
• White M C, Kohner E M, Pickup J C. Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: A case report. Br J Ophthalmol 1981; 65: 307–311
   Web of Science ®Google Scholar
• Pickup J C, Keen H, Viberti G C. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 1980; 3: 290–300
   PubMed Web of Science ®Google Scholar
• Tamborlane W V, Pucklin J E, Bergman M. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982; 5: 58–64
   PubMed Web of Science ®Google Scholar
• Daneman D, Drash A L, Lobes L A. Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care 1981; 4: 360–365
   PubMed Web of Science ®Google Scholar
• Champion M C, Keen H, Pickup J C. for the Kroc Collaborative Study Group: Origin and design of the Kroc Collaborative Study. Diabetes 1985; 34: 5–12, (suppl 3)
   Google Scholar
• Davis M D, Hubbard L D, Trautman J, For the Kroc Collaborative Study Group. Studies of retinopathy. Methodology for assessment and classification with fundus photographs. Diabetes 1985; 34: 42–49, (suppl 3)
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study. Manual of Operations. Public Health Service, Bethesda, MD 1980
   Google Scholar
• Canny C LB, Kohner E M, Trautman J, For the Kroc Collaborative Study Group. Comparison of streofundus photographs in patients with insulin-dependent diabetes during conventional insulin treatment or continuous subcutaneous insulin infusion. Diabetes 1985; 34: 50–55, (suppl 3)
   Google Scholar
• Kohner E M, Lawson P M, Ghosh G, For the Kroc Collaborative Study Group. Assessment of fluorescein angiograms. Diabetes 1985; 34: 56–60
   Google Scholar
• Klein B EK, Davies M D, Segal P. Diabetic retinopathy: Assessment of severity and progression. Ophthalmology 1984; 91: 10–17
   PubMed Web of Science ®Google Scholar
• Tamborlane W V, Champion M C, Rizza R A. for the Kroc Collaborative Study Group: Observations on control of glycaemia with conventional insulin therapy or continuous subcutaneous insulin infusion. Diabetes 1985; 34: 22–26
   Google Scholar
• The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria; A preliminary multicentre trial. N Engl J Med 1984; 311: 365–372
   PubMedGoogle Scholar
• Keen H. Normoglycaemic re-entry and diabetic complications. Diabetic Med 1984; 1: 85–87
   PubMedGoogle Scholar
• Lauritzen T, Frost-Larsen K, Larsen H-W, The Steno Study Group. Effect of 1 year near-normal blood glucose levels in retinopathy in insulin-dependent diabetics. Lancet 1983; 1: 200–204
   PubMed Web of Science ®Google Scholar
• Dahl-Jorgensen K, Brinchmann-Hansen O, Hansen K F. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: The Oslo Study. Br Med J 1985; 290: 811–815
   PubMed Web of Science ®Google Scholar
• The Kroc Collaborative Study Group. The Kroc Study patients at two years: A report on further retinal changes. Diabetes 1985; 34: 39A, (suppl 1; abstr)
   Google Scholar
• Lauritzen T, Frost-Larsen K, Larsen H-W. the Steno Study Group: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34: 74–79, (suppl 3)
   PubMed Web of Science ®Google Scholar
• Dahl-Jorgensen K, Hanssen K F, Brinchmann-Hansen O. Near-normoglycaemia retards the progression of early retinopathy and neuropathy in IDDM. Three years results from the Oslo Study. Diabetes 1986; 35: 41A, (suppl 1; abstr)
   Google Scholar
• The DCCT Research Group. Results of feasibility phase of the Diabetes Control and Complications Trial (DCCT): Glycaemic control, follow-up and complications of therapy. Diabetes 1986; 35: 3A, (suppl 1; abstr)
   Google Scholar